Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1995-06-06
1998-05-26
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
264 41, 264 43, A61K 9127, A61K 9133
Patent
active
057561214
ABSTRACT:
A liposomal aminoglycoside formulation comprising a neutral lipid, a negatively charged lipids and a sterol. The formulation contains unilamellar vesicles having an average size below 100 nm. A process of making liposomes containing an aminoglycoside is provided where the hydration temperature is significantly below the transition temperature of the formulation. A method for the treatment of drug susceptible and drug resistant bacteria.
REFERENCES:
patent: 4508703 (1985-04-01), Redniziak et al.
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4621023 (1986-11-01), Redniziak et al.
patent: 4753788 (1988-06-01), Gamble
patent: 4762720 (1988-08-01), Jizomoto
patent: 4897384 (1990-01-01), Janoff et al.
patent: 4933121 (1990-06-01), Law et al.
patent: 4946683 (1990-08-01), Forssen
patent: 4952405 (1990-08-01), Yau-Young
patent: 4981692 (1991-01-01), Popescu et al.
patent: 5000887 (1991-03-01), Tenzel et al.
patent: 5023087 (1991-06-01), Young
patent: 5043107 (1991-08-01), Moore
patent: 5043165 (1991-08-01), Radhakrishnan
patent: 5043166 (1991-08-01), Barenholz
patent: 5053217 (1991-10-01), Lehigh
patent: 5211955 (1993-05-01), Legros et al.
patent: 5270052 (1993-12-01), Gelfond
patent: 5276452 (1994-01-01), Hope
patent: 5409704 (1995-04-01), Bally
Bakker-Woudenberg et al., Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae--Infected lung tissue, J. Infect. Dis. 171:938-947, 1995.
Bermudez et al., "Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides," J. Infect. Dis. 161:1262-1268, 1990.
Bermudez et al., "Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin," J. Infect. Dis. 156(3):510-513, 1987.
Bonventre & Gregoriadis, "Killing of intraphagocytic staphylococcus aureus by dihydrostreptomycin entrapped within liposomes," Antimicrobial Agents and Chemotherapy 13(6):1049-1051, 1978.
Gangadharam et al., "Comparative activities of free and liposome encapsulated amikacin against mycobacterium avium complex (MAC)," Liposomes in the Therapy of Infectious Diseases and Cancer, pp. 177-190, Alan R. Liss, Inc., 1989.
Guzgunes et al., "Treatment of mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: Role of liposome type and duration of treatment," J. Infect. Dis. 164:143-151, 1991.
Karlowsky and Zhanel, "Concepts on the use of liposomal antimicrobial agents: Applications for aminoglycosides," Clinical Infect. Dis. 15:654-667, 1992.
Majumdar et al., "Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages," Antimicrobial Agents & Chemotherapy 36(12):2808-2815, 1992.
Saito and Tomioka, "Therapeutic efficacy of liposome-entrapped rifampin against mycobacterium avium complex infection induced in mice," Antimicrobial Agents & Chemotherapy 33(4):429-433, 1989.
Schreier et al., "Sustained release of liposome-encapsulated gentamicin and fate of phospholipid following intramuscular injection in mice," J. Controlled Release 5:187-192, 1987.
Stevenson et al., "Enhanced activity of streptomycin and chloramphenicol against intracellular escherichia coli in the J774 macrophage cell line mediated by liposome delivery," Antimicrobial Agents & Chemotherapy 24(5):742-749, 1983.
Tadakuma et al., "Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes," Antimicrobial Agents & Chemotherapy 28(1):28-32, 1985.
International Search Report dated 22 Sep. 1993.
Dialog Information Services, File 73 Embase, Dialog accession No. 8333576, Embase accession No. 92010722 Wichert B.V. et al.
Fountain, Michael W., et al., "Enhanced Intracellular Killing of Staphylococcus Aureus by Canine Monocytes Treated with Liposomes Containing Amikacin, Gentamicin, Kanamycin, and Tobramycin.", Current Microbiology, vol. 6:373-376 (1981).
Fountain, Michael et al., Liposome-Cell Interactions a Rapid Assay For Cells In Suspension Cultu Biochimica et Biophysica Acta, 596:420-425 (1980).
Dees, C. et al., "Enhanced Intraphagocytic Killing of Brucella Abortus in Bovine Monouclear Cells Liposomes-Containing Gentamicin." Veterinary Immunology and Immunopathology, vol. 8:171-18 (1985).
Barza, Michael et al., "Pharmacokinetics of Subconjunctival Liposome-Encapsulated Gentamicin i Normal Rabbit Eyes." Investigative Ophthalmology and Visual Science, vol. 25:486-490, (Apr. 19.
Fishman, Peggy, et al., "Intravitreal Liposomes-Encapsulated Gentamicin in a Rabbit Model." Investigative Ophthalmology and Visual Science, vol. 27:1103-1106 (Jul. 1986).
Kubo, Masaharu, et al., "Binding of Propranolo and Gentamicin to Small Unilamellar Phospholipid Vesicles." Biochemical Pharmacology, vol. 35, No. 21:3761-3765 (1986).
Gabizon, A., "Liposome as in Vvio carriers of Adrizmycin: Reduced cardiac uptake and preserved antitumor activity in mice", Cancer Research 42, Nov. 1982, pp. 4734-4739.
Crommelin, D.J.A., "Preparation and characterization of doxorubicin-containing liposomes: I. Influence of liposome charge and pH of hydration medium on loading capacity and particle size", International Journal of Pharmaceutics, 16, (1983), pp. 79-92.
Rosa, P. "Liposomes containing Doxorubicin: An example of drug targeting", Transport in Biomembranes, 1982, p. 243.
Abstract: Wichert, el al., "Characterization, aerosolization, and in vitro activity against Mycobacterium avium-intracellulare in alveolar macrophages," Int. J. Pharm., 78/2-3:227-235 (1992).
Duzgunes, Antimicrobial Agents and Chemotherapy, pp. 1404-1411, Sep. 1988.
Kishore Gollamudi S.
NeXstar Pharmaceuticals, Inc.
LandOfFree
Antibiotic formulation and use for drug resistant infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibiotic formulation and use for drug resistant infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibiotic formulation and use for drug resistant infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1957459